Volunteer Assignments and Opportunities: Difference between revisions
No edit summary |
Snehal.Patel (talk | contribs) No edit summary |
||
| (17 intermediate revisions by 4 users not shown) | |||
| Line 344: | Line 344: | ||
| | | | ||
|Jennelle Hodge (JH)/ Malini Sathanoori (MS) | |Jennelle Hodge (JH)/ Malini Sathanoori (MS) | ||
| | |04/26/2021 -MS (re-review) | ||
| | | | ||
|- | |- | ||
| Line 360: | Line 360: | ||
|PENDING | |PENDING | ||
| ||JH / MS | | ||JH / MS | ||
| | |04/26/2021 -MS (re-review) | ||
| | | | ||
|- | |- | ||
| Line 400: | Line 400: | ||
|Complete | |Complete | ||
| ||JH / MS | | ||JH / MS | ||
| | |04/26/2021 -MS (re-review) | ||
| | | | ||
|- | |- | ||
| Line 417: | Line 417: | ||
|Complete | |Complete | ||
| ||JH / MS | | ||JH / MS | ||
|04/26/2021-MS (re-review) | |||
| | | | ||
|- | |- | ||
| Acute Myeloid Leukemia with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11||Disease||Christine Bryke | | Acute Myeloid Leukemia with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11||Disease||Christine Bryke | ||
| Line 834: | Line 834: | ||
| | | | ||
|- | |- | ||
| B-Lymphoblastic Leukemia/Lymphoma, Not Otherwise Specified||Disease|| | | B-Lymphoblastic Leukemia/Lymphoma, Not Otherwise Specified||Disease||Holli Drendel | ||
| | | | ||
| | | | ||
|PENDING | |||
| ||YA | | ||YA | ||
| | | | ||
| | | | ||
|- | |- | ||
| | |B-Lymphoblastic Leukemia/Lymphoma with t(4;14)(q35.2;q32); IGH/DUX4 | ||
|Disease | |||
|Diana Rush | |||
| | | | ||
| | | | ||
|PENDING | |||
| | | | ||
|YA | |||
| | | | ||
|NON-WHO ENTITY | |||
|- | |- | ||
| | |B-Lymphoblastic Leukemia/Lymphoma with dic(9;12)(p13;p13); PAX5/ETV6 | ||
|Disease | |||
|Celeste Eno | |||
| | | | ||
| | | | ||
|PENDING | |||
| | | | ||
|YA | |||
| | | | ||
|NON-WHO ENTITY | |||
|- | |- | ||
| | |B-Lymphoblastic Leukemia/Lymphoma with ZNF384 Rearrangements | ||
|Disease | |||
|Marilena Melas | |||
| | | | ||
| | | | ||
|PENDING | |||
| | | | ||
|YA | |||
| | | | ||
|NON-WHO ENTITY | |||
|- | |- | ||
|B-Lymphoblastic Leukemia/Lymphoma with | |B-Lymphoblastic Leukemia/Lymphoma with IKZF1 Deletions | ||
|Disease | |Disease | ||
| | |Chenkai Ma | ||
| | | | ||
| | | | ||
| Line 877: | Line 886: | ||
|NON-WHO ENTITY | |NON-WHO ENTITY | ||
|- | |- | ||
| || | |B-Lymphoblastic Leukemia/Lymphoma with TCF3 Rearrangements - Excluding t(1;19) and t(12;19) | ||
|Disease | |||
|Celeste Eno | |||
| | | | ||
| | | | ||
|PENDING | |||
| | | | ||
| | |YA | ||
| | | | ||
|NON-WHO ENTITY | |||
|- | |- | ||
| | |B-Lymphoblastic Leukemia/Lymphoma with dic(9;20)(p13;q11) | ||
|Disease | |||
|Alaa Koleilat | |||
| | | | ||
| | | | ||
|PENDING | |||
| | | | ||
| | |YA | ||
| | | | ||
|NON-WHO ENTITY | |||
|- | |- | ||
| | |'''''T-Lymphoblastic Leukemia/Lymphoma'''''||'''''Overview'''''||Fei Yang | ||
| | | | ||
| | | | ||
|PENDING | |PENDING | ||
| | | ||YA | ||
| | |||
| | | | ||
| | | | ||
|- | |- | ||
| | |Early T-Cell Precursor Lymphoblastic Leukemia||Disease||Fei Yang | ||
| | | | ||
| | | | ||
|PENDING | |PENDING | ||
| | | ||YA | ||
| | |||
| | | | ||
| | | | ||
|- | |- | ||
| | |NK-Lymphoblastic Leukemia/Lymphoma||Disease||Fei Yang | ||
| | | | ||
| | | | ||
|PENDING | |PENDING | ||
| | | ||YA | ||
| | |||
| | | | ||
| | | | ||
|- | |- | ||
| | | || || | ||
| | | | ||
| | | | ||
| | | | ||
| | | || | ||
| | | | ||
| | | | ||
|- | |- | ||
| | |'''''Mature B-Cell Neoplasms'''''||'''''Overview'''''|| | ||
| | | | ||
| | | | ||
| | | | ||
|SP | | ||Snehal Patel (SP) | ||
| | | | ||
| | | | ||
|- | |- | ||
| | |Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma||Disease|| | ||
| | |||
| | | | ||
| | | | ||
| | | | ||
|SP | |SP | ||
| Line 947: | Line 957: | ||
| | | | ||
|- | |- | ||
| | | Monoclonal B-cell Lymphocytosis||Disease|| | ||
| | |||
| | | | ||
| | | | ||
| | | | ||
|SP | |SP | ||
| Line 956: | Line 966: | ||
| | | | ||
|- | |- | ||
| | |B-cell Prolymphocytic Leukemia||Disease|| | ||
| | |||
| | | | ||
| | | | ||
| | | | ||
|SP | |SP | ||
| Line 965: | Line 975: | ||
| | | | ||
|- | |- | ||
| | |Splenic Marginal Zone Lymphoma||Disease||Snehal Patel | ||
| | | | ||
| | | | ||
| | |Complete | ||
| | | | ||
|SP | |SP | ||
| Line 974: | Line 984: | ||
| | | | ||
|- | |- | ||
| | |Hairy Cell Leukemia||Disease||Snehal Patel | ||
| | | | ||
| | | | ||
| | |Complete | ||
| | | | ||
|SP | |SP | ||
| Line 983: | Line 993: | ||
| | | | ||
|- | |- | ||
| | |'''''Splenic B-cell Lymphoma/Leukemia, Unclassifiable'''''||'''''Overview'''''||Snehal Patel | ||
| | | | ||
| | | | ||
|Complete | |||
| | | | ||
|SP | |||
| | | | ||
| | | | ||
|- | |- | ||
| | | Splenic Diffuse Red Pulp Small B-cell Lymphoma||Disease||Snehal Patel | ||
| | | | ||
| | | | ||
|Complete | |||
| | | | ||
|SP | |||
| | | | ||
| | | | ||
|- | |- | ||
| | | Hairy Cell Leukemia Variant||Disease||Snehal Patel | ||
| | | | ||
| | | | ||
|Complete | |||
| | | | ||
|SP | |||
| | | | ||
| | | | ||
|- | |- | ||
| | |Lymphoplasmacytic Lymphoma||Disease|| | ||
| | |||
| | | | ||
| | | | ||
| | | | ||
| | | | ||
|SP | |||
| | | | ||
| | | | ||
|- | |- | ||
| | | Waldenstrom Macroglobulinemia||Disease|| | ||
| | | | ||
| | | | ||
| Line 1,032: | Line 1,038: | ||
| | | | ||
|- | |- | ||
| | |IgM Monoclonal Gammopathy of Undetermined Significance||Disease|| | ||
| | | | ||
| | | | ||
| | | | ||
| | | ||SP | ||
|SP | |||
| | | | ||
| | | | ||
|- | |- | ||
| | |'''''Heavy Chain Diseases'''''||'''''Overview'''''|| | ||
| | | | ||
| | | | ||
| | | | ||
|SP | | ||SP | ||
| | | | ||
| | | | ||
|- | |- | ||
| | | Mu Heavy Chain Disease||Disease|| | ||
| | | | ||
| | | | ||
| | | | ||
|SP | | ||SP | ||
| | | | ||
| | | | ||
|- | |- | ||
| | | Gamma Heavy Chain Disease||Disease||Manisha Sutariya | ||
| | | | ||
| | | | ||
| | |Complete | ||
| | |5/26/2021||SP | ||
|SP | |||
| | | | ||
| | | | ||
|- | |- | ||
| | | Alpha Heavy Chain Disease||Disease|| | ||
| | | | ||
| | | | ||
| Line 1,076: | Line 1,078: | ||
| | | | ||
|- | |- | ||
| | |Plasma Cell Neoplasms||'''''Overview'''''||Zhenya Tang | ||
| | | | ||
| | | | ||
|PENDING | |||
| | | | ||
|SP | |||
| | | | ||
| | | | ||
|- | |- | ||
| | | Non-IgM Monoclonal Gammopathy of Undetermined Significance||Disease||Zhenya Tang | ||
| | | | ||
| | | | ||
|PENDING | |||
| | | | ||
|SP | |||
| | | | ||
| | | | ||
|- | |- | ||
| | | Plasma Cell Myeloma||Disease||Zhenya Tang/Huang Mo (trainee) | ||
| | | | ||
| | | | ||
|PENDING | |||
| | | | ||
|SP | |||
| | | | ||
| | | | ||
|- | |- | ||
| | | Plasma Cell Myeloma Variants||Disease||Fariborz Rashid-Kolvear | ||
| | | | ||
| | | | ||
|PENDING | |||
| | | | ||
|SP | |||
| | | | ||
| | | | ||
|- | |- | ||
| | | Plasmacytoma||Disease||Zhenya Tang | ||
| | | | ||
| | | | ||
|PENDING | |||
| | | | ||
|SP | |||
| | | | ||
| | | | ||
|- | |- | ||
| | |''''' Monoclonal Immunoglobulin Deposition Diseases'''''||'''''Overview'''''|| | ||
| | | | ||
| | | | ||
| | | | ||
|SP | | ||SP | ||
| | | | ||
| | | | ||
|- | |- | ||
| | | Primary Amyloidosis||Disease|| | ||
| | |||
| | | | ||
| | | | ||
| ||SP | | ||SP | ||
| | | | ||
| | | | ||
|- | |- | ||
| | | Light Chain and Heavy Chain Deposition Disease||Disease|| | ||
| | |||
| | | | ||
| | | | ||
| | | ||SP | ||
| | |||
|SP | |||
| | | | ||
| | | | ||
|- | |- | ||
| | |'''''Plasma Cell Neoplasms with Associated Paraneoplastic Syndrome'''''||'''''Overview'''''|| | ||
| | | | ||
| | | | ||
| | | | ||
|SP | | ||SP | ||
| | | | ||
| | | | ||
|- | |- | ||
| | | POEMS Syndrome||Disease|| | ||
| | | | ||
| | | | ||
|PENDING | | | ||
| ||SP | |||
| | |||
| | |||
|- | |||
| TEMPI Syndrome||Disease|| | |||
| | |||
| | |||
| | |||
| ||SP | |||
| | |||
| | |||
|- | |||
|Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue (MALT Lymphoma)||Disease||Whayoung Lee, trainee)/Fabiola Quintero-Rivera | |||
|3/9/21 | |||
| | |||
|PENDING | |||
| | | | ||
|SP | |SP | ||
| Line 1,160: | Line 1,180: | ||
| | | | ||
|- | |- | ||
| In Situ Follicular Neoplasia||Disease||Ruthann Pfau | |Nodal Marginal Zone Lymphoma||Disease||Shivani Golem | ||
| | | | ||
| | | | ||
|PENDING | |Complete | ||
| | |5/28/2021||SP | ||
|SP | | | ||
| | | | ||
| | |- | ||
|- | | Paediatric Nodal Marginal Zone Lymphoma||Disease||Ruthann Pfau, Kathleen Schieffer (trainee) | ||
| Duodenal-Type Follicular Lymphoma||Disease||Ruthann Pfau | | | ||
| | | | ||
| | |Complete | ||
|PENDING | |11/11/2020 | ||
| | |SP | ||
|SP | | | ||
| | | | ||
| | |- | ||
|- | |Follicular Lymphoma||Disease||Ruthann Pfau | ||
|Paediatric-Type Follicular Lymphoma||Disease||Ruthann Pfau, Kathleen Schieffer (trainee) | | | ||
| | | | ||
| | |PENDING | ||
| | |||
|SP | |||
| | |||
| | |||
|- | |||
| Testicular Follicular Lymphoma||Disease||Ruthann Pfau | |||
| | |||
| | |||
|PENDING | |||
| | |||
|SP | |||
| | |||
| | |||
|- | |||
| In Situ Follicular Neoplasia||Disease||Ruthann Pfau | |||
| | |||
| | |||
|PENDING | |||
| | |||
|SP | |||
| | |||
| | |||
|- | |||
| Duodenal-Type Follicular Lymphoma||Disease||Ruthann Pfau | |||
| | |||
| | |||
|PENDING | |||
| | |||
|SP | |||
| | |||
| | |||
|- | |||
|Paediatric-Type Follicular Lymphoma||Disease||Ruthann Pfau, Kathleen Schieffer (trainee) | |||
| | |||
| | |||
|Complete | |||
|8/16/2020 | |||
|SP | |||
| | |||
| | |||
|- | |||
|Large B-cell Lymphoma with IRF4 Rearrangement||Disease||Afia Hasnaid | |||
| | |||
|9/30/20 | |||
|Complete | |Complete | ||
| | |5/26/2021||SP | ||
| | | | ||
| | | | ||
| Line 2,701: | Line 2,756: | ||
| | | | ||
|- | |- | ||
| | |BRCA1 | ||
| | | | ||
| | | | ||
| Line 2,711: | Line 2,766: | ||
| | | | ||
|- | |- | ||
| | |BRCA2 | ||
| | | | ||
| | | | ||